Aventis supervisory board rejects Sanofi takeover bid
17 February 2004 19:44 [Source: ICIS news]
LONDON (CNI)--The supervisory board of Franco-German life sciences group Aventis agreed unanimously on Tuesday to reject the hostile takeover bid formally launched today by French pharmaceuticals rival Sanofi-Synthélabo.Aventis' supervisory board concluded unanimously that Sanofi's share and cash offer, which is valued at around Euro47bn ($60bn) was "clearly inadequate" financially.
In addition, the board said the offer entailed important social risks with limited benefits for Aventis and recommended shareholders not to accept it.
The supervisory board directed Aventis' management board "to study all alternatives with stronger industrial, social and financial rationale in the interest of the shareholders and employees of Aventis".
Aventis chairman Igor Landau has already condemned the offer as "cheap and ridiculous".
By: Neil Sinclair
+44 20 8652 3214
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
| ICIS news FREE TRIAL |
| Get access to breaking chemical news as it happens. |
| ICIS Global Petrochemical Index (IPEX) |
| ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index |
Related Articles
- 05 Apr 04 18:26 French govt yet to be won over in weighing Aventis' fate
- 05 Apr 04 13:40 EC review on Sanofi bid for Aventis delayed to 26 April
- 31 Mar 04 17:06 Sanofi files bid for Aventis with SEC, Novartis silent
- 05 Mar 04 19:44 Aventis spotlights job cuts as key to Sanofi cost cut plan
- 05 Mar 04 11:25 Aventis spells out its case against Sanofi hostile bid
- 20 Feb 04 19:34 Aventis appeal forces AMF to keep open Sanofi hostile bid
- 16 Feb 04 18:26 Sanofi steady in Aventis pursuit, offer premium unmoved
- 16 Feb 04 17:11 Sanofi '03 profits up; pushes R&D strengths for Aventis bid
- 13 Feb 04 15:49 Aventis launches legal challenge to Sanofi takeover bid
- 12 Feb 04 19:59 Sanofi gets French stock mkt clearance to launch Aventis bid
- 10 Feb 04 17:20 French union seeks job safeguards over Sanofi bid for Aventis
- 05 Feb 04 17:32 Aventis sets new product sales target in battle with Sanofi
- 29 Jan 04 13:34 Aventis CEO says Sanofi bid 'at least 40-50% too low'
- 27 Jan 04 18:55 'We don't need Sanofi, they need us' says Aventis CEO
- 26 Jan 04 13:11 Aventis rejects "hostile" takover bid by Sanofi-Synthelabo, mulls "other scenarios"
- 26 Jan 04 09:59 Sanofi-Synthelabo launches hostile bid for Aventis to create pharma giant
Latest News
- 18 May 13 00:01 Indiana pulls nitrogen plant funding over fears about explosives
- 17 May 13 23:59 Europe May EO contracts fall in line with ethylene decrease
- 17 May 13 23:59 Europe May DMT reference prices roll over in line with feedstocks
- 17 May 13 23:59 Europe May purified terephthalic acid contract prices roll over
- 17 May 13 23:59 Europe May MMA contract prices dip on softer market fundamentals